5-Amino-1MQ mouse-study findings
5-Amino-1MQ 50mg Pen is a pre-filled catalogue presentation. The cited research concerns laboratory cells and mice, not a clinical pen trial. The original manuscript describes randomized cohorts of diet-induced-obese male mice, with nine mice per cohort, studied over 11 days. Original NNMT-inhibitor study.
The experiment measured body weight and food intake alongside fat-pad weight, adipocyte size and plasma cholesterol. The endpoints are different: a body-weight measurement is not the same observation as a fat-cell measurement or plasma cholesterol. Original NNMT-inhibitor study.
NNMT inhibition in cell experiments
The study identifies 5-amino-1MQ among small-molecule inhibitors of nicotinamide-N-methyltransferase, or NNMT, examined in pre-adipocytes. In cultured adipocytes, investigators measured intracellular 1-MNA to assess NNMT inhibition. Original NNMT-inhibitor study.
The 1-MNA measurement and the mouse outcomes belong to different stages of the investigation. A cellular inhibition readout does not itself measure weight change in people. Nor does the 11-day mouse experiment establish a human benefit or a human safety profile. Original NNMT-inhibitor study.
50mg pen presentation
This listing identifies a pre-filled pen and a 50mg catalogue amount. It does not identify a formulation proven equivalent to the research material. Original NNMT-inhibitor study.
A useful comparison is the separately documented 5 Amino 1MQ 50MG vial. Its listed amount can be compared with the pen's literal name, while the NNMT and mouse evidence remains attached to the original study. Similar mass wording does not establish matching delivery or biological performance. Original NNMT-inhibitor study.
5-Amino-1MQ classification
Is 5-amino-1MQ a peptide?
The original NNMT-inhibitor study describes it as a small molecule. Its placement in this catalogue does not change that research identity. Original NNMT-inhibitor study.
